Pancreatic Cancer Clinical Trials: Find New Options

Last updated and reviewed on June 24, 2026.

For pancreatic cancer, clinical trials are not just an option of last resort. They are one of the most important pathways to accessing better treatments, and many pancreatic cancer specialists recommend discussing trial options at the very beginning of care, not only after standard treatments have been exhausted. Every treatment currently used for pancreatic cancer, from FOLFIRINOX chemotherapy to olaparib for BRCA-mutated tumors, became available because patients before you participated in clinical trials and helped researchers prove those treatments worked. Taking part in a trial today helps build the evidence that will change the outlook for future patients.

Should I Join a Clinical Trial?

The decision to join a clinical trial is personal, and there is no single right answer. But there are several compelling reasons why pancreatic cancer patients in particular should seriously consider it.

1. The current standard treatments for most patients with advanced pancreatic cancer extend life and improve quality of life, but they rarely produce cures. Clinical trials offer access to new drugs, new drug combinations, immunotherapies, targeted therapies, and experimental approaches that are not available outside of research settings and that may one day prove more effective than what currently exists.
2. For patients whose tumors have molecular features that may predict response to specific drugs (like BRCA mutations, MSI-H status, or KRAS mutations), trials targeting those features may offer meaningful benefit over standard chemotherapy.
3. Participation in a trial provides access to expert care. Trials are typically run at academic medical centers or cancer research centers with specialized expertise in pancreatic cancer, and participants receive close monitoring and follow-up throughout.
4. Even if a trial does not ultimately benefit the individual participant, participation contributes to progress. Pancreatic cancer research has long been underfunded relative to more common cancers, and patient participation is one of the most powerful drivers of research momentum.

A common misconception: Many people believe clinical trials involve receiving a placebo (sugar pill) instead of real treatment. In cancer clinical trials, giving a placebo alone when an effective treatment exists would be unethical. You will always receive at least the current standard of care, and the experimental arm of the trial is tested on top of that or compared directly to it.

Will My Insurance Cover a Clinical Trial?

This is one of the most common and practical questions patients ask, and it is worth understanding before you commit to any particular trial.

• Federal law provides some protections: The Affordable Care Act (ACA) requires most insurance plans to cover the routine care costs of participating in a clinical trial. This means that standard costs you would incur even if you were not in a trial, such as doctor visits, blood tests, imaging, and treatment to manage side effects, must be covered by your insurance. However, the experimental drug or device being tested in the trial, and any tests or visits that are purely research-related, are typically paid for by the trial sponsor (usually a pharmaceutical company, the National Cancer Institute, or a research institution), not by your insurance.
• Medicare beneficiaries: Have coverage for routine care costs in qualifying clinical trials under the Medicare Clinical Trial Policy.
• Medicaid: Coverage varies by state. Some states cover routine care costs in clinical trials for Medicaid patients, but others do not. Check with your state's Medicaid program.
• Always clarify costs before enrolling: Before you sign a consent form for any clinical trial, ask the research team for a detailed breakdown of what costs the trial will cover, what your insurance is expected to cover, and whether there are any out-of-pocket costs you should expect. Ask to speak with the trial's billing coordinator or patient financial advocate if you have questions. Do not let cost assumptions stop you from considering a trial without getting the specific facts for your situation.

How to Find Pancreatic Cancer Clinical Trials

HealthTree Clinical Trial Finder can help you identify trials relevant to your diagnosis and history.

Search For Pancreatic Cancer Clinical Trials

When searching, it is helpful to have your complete pathology report, molecular testing results (including KRAS mutation status, BRCA status, MSI/MMR status, and any other mutations identified), and your current stage and treatment history, which will help you identify trials for which you might be eligible.

Sources:

1. National Cancer Institute. Understanding Clinical Trials. https://www.cancer.gov/about-cancer/treatment/clinical-trials/what-are-trials
2. American Cancer Society. What Are Clinical Trials? https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/what-you-need-to-know.html
3. Centers for Medicare and Medicaid Services. Clinical Trials Coverage. https://www.cms.gov/Medicare/Coverage/ClinicalTrialPolicies
4. Golan T, et al. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. New England Journal of Medicine. 2019;381(4):317-327. https://www.nejm.org/doi/full/10.1056/NEJMoa1903387